Bemcentinib-d8

(Synonyms: R428-d8; BGB324-d8)

Bemcentinib-d8 (R428-d8) is the deuterium labeled Bemcentinib (HY-15150). Bemcentinib (R428) is a selective and orally active Axl inhibitor with an IC50 of 14 nM. Bemcentinib retards cancer cell migration and invasion. Bemcentinib exhibits >100-fold selectivity for Axl versus Abl and 50- and >100-fold selectivity over TAM family kinases Mer and Tyro3, respectively, in cells. Bemcentinib blocks tumor spread and prolongs survival in models of metastatic breast cancer.

For research use only. We do not sell to patients.

  • Formula: C30H26D8N8
  • Molecular Weight:514.69
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

All TAM Receptor Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00